TRPM7 Deficiency Protects Against Myocardial Ischemia-Reperfusion Injury by Regulating Intracellular Zn 2+ Homeostasis
Circulation · 21.04.2026 · 153 (16) · 1210-1229
DOI: 10.1161/circulationaha.125.074791 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 21.04.2026. Verfasst von Xin Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Pat and Jim Calhoun Cardiology Center (Xin Li, Xiaohan Li, C.X.L., J.F., Z.Y., L.Y.), University of Connecticut School of Medicine, Farmington. Hauptthemen laut MEDLINE: TRPM Cation Channels, Myocardial Reperfusion Injury, Zinc, Myocytes, Cardiac. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAAA NIH HHS, NHLBI NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Ischemic heart disease is one of the leading causes of death worldwide. Timely reperfusion is necessary for myocardium salvage but triggers paradoxical cardiomyocyte death and contributes to up to 50% of the final infarct size, known as lethal ischemia/reperfusion (I/R) injury. TRPM7 (transient receptor potential melastatin 7) is a divalent cation–permeable, nonselective channel kinase that can sense oxidative stress and release Zn 2+ from unique intracellular TRPM7 vesicles. However, the pathophysiological role of intracellular TRPM7 remains poorly understood. METHODS: TRPM7 expression was determined in hearts from patients with ischemic heart failure and I/R-injured mice. Global ( gTrpm7 -/- ), cardiomyocyte-specific ( cmTrpm7 −/− ), and fibroblast-specific ( fibTrpm7 −/− ) Trpm7 knockout mice were used to determine the role of TRPM7 in I/R injury. Mechanistic investigations were conducted in neonatal and adult mouse cardiomyocytes and human induced pluripotent stem cell–derived cardiomyocytes (hiPSC-CMs) with patch-clamp, Zn 2 + imaging, and molecular biology techniques. An inducible TRPM7 channel-dead (TRPM7-E1047K) knock-in mouse model was generated to elucidate the functional domains of TRPM7 for therapeutic strategies. RESULTS: We found that TRPM7 was significantly upregulated in myocardium from both patients with ischemic heart failure and I/R-injured mice. Global TRPM7 deficiency markedly reduced infarct size and improved cardiac function after I/R injury. Using cmTrpm7 −/− and fibTrpm7 −/− mice, we demonstrated that TRPM7 deficiency in myocytes, rather than in fibroblasts, confers protection against I/R injury by inhibiting pyroptosis as evaluated. Furthermore, using mouse cardiomyocytes and hiPSC-CMs, we revealed that Zn 2+ release from intracellular TRPM7 vesicles during I/R injury triggers cardiomyocyte death by activating gasdermin-D to release its N-terminal and form the membrane pore. The critical role of intracellular TRPM7 was further supported by the inability of membrane TRPM7 inhibition to protect mice against I/R injury. To elucidate whether the channel or kinase activity of TRPM7 mediates pyroptosis in I/R injury, we generated an inducible channel-dead TRPM7-E1047K knock-in mouse model. By comparing with kinase-inactive TRPM7 knock-in mice, we uncovered that the channel but not the kinase function of TRPM7 mediates I/R injury. CONCLUSIONS: TRPM7-mediated intracellular Zn 2 + release contributes to myocardial I/R injury by triggering apoptotic and pyroptotic cardiomyocyte death. Given that TRPM7 is highly upregulated in patients with ischemic heart failure, our findings suggest that targeting TRPM7 may represent a novel therapeutic strategy for ischemic heart disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pat and Jim Calhoun Cardiology Center (Xin Li, Xiaohan Li, C.X.L., J.F., Z.Y., L.Y.), University of Connecticut School of Medicine, Farmington.
- Department of Cell Biology (Xin Li, Xiaohan Li, C.X.L., J.F., Z.Y., L.Y.), University of Connecticut School of Medicine, Farmington.
- Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT (Xin Li, Y.Q.).
- Yale Stem Cell Center (Xin Li, Y.Q.), Yale School of Medicine, New Haven, CT.
- Department of Pathology (Xin Li, Y.Q.), Yale School of Medicine, New Haven, CT.
- Department of Physiology and Cell Biology, College of Medicine/Wexner Medical Center, The Ohio State University, Columbus (J.Y., X.A.).
ORCID-Profile: Xin Li, Cindy Xintong Li, Yibing Qyang, Loren W Runnels, Xun Ai, Lixia Yue
Förderung
- NIAAA NIH HHS
- NHLBI NIH HHS
- NINDS NIH HHS
Zitieren
APA
Li, X., Li, X., Li, C. X., Feng, J., Yue, Z., Yan, J., Matsushita, M., Qyang, Y., Runnels, L. W., Ai, X., & Yue, L. (2026). TRPM7 Deficiency Protects Against Myocardial Ischemia-Reperfusion Injury by Regulating Intracellular Zn 2+ Homeostasis. Circulation, 153(16), 1210-1229. https://doi.org/10.1161/circulationaha.125.074791
Vancouver
Li X, Li X, Li CX, Feng J, Yue Z, Yan J, et al. TRPM7 Deficiency Protects Against Myocardial Ischemia-Reperfusion Injury by Regulating Intracellular Zn 2+ Homeostasis. Circulation. 2026;153(16):1210-1229. doi:10.1161/circulationaha.125.074791
BibTeX
@article{Li2026,
author = {Li, Xin and Li, Xiaohan and Li, Cindy Xintong and Feng, Jianlin and Yue, Zhichao and Yan, Jiajie and Matsushita, Masayuki and Qyang, Yibing and Runnels, Loren W and Ai, Xun and Yue, Lixia},
title = {TRPM7 Deficiency Protects Against Myocardial Ischemia-Reperfusion Injury by Regulating Intracellular Zn 2+ Homeostasis},
journal = {Circulation},
year = {2026},
volume = {153},
number = {16},
pages = {1210--1229},
doi = {10.1161/circulationaha.125.074791}
}
EUVIMED